WHO WE ARE / SINCE 2003

Twenty years.
One stubborn
idea.

Better clinical trials happen when the people running them care about the science and the deadline. That's the whole company.

We are a CRO that
still reads protocols.

Founded in 2003 in Berlin, CSG was built on a single principle: the difference between a useful clinical trial and a wasted one is human judgement. Spreadsheets help. Software helps. But somewhere in the chain, a person has to read the protocol and say "this won't work — and here's why."

Twenty years and 150 trials later, we still do that. We're a mid-sized CRO by design — small enough that the person you meet at kickoff is the person on your study, large enough to run a 30-country phase III without flinching.

We operate as part of the IGES Group — Germany's largest independent health-research network — which gives us reach into health economics, registry research, and policy without losing the focus that makes us good at what we do.

"If your CRO can't tell you why your endpoint is wrong before you submit, you've hired the wrong CRO." — DR. ANNA WEBER, MANAGING DIRECTOR
Placeholder timeline — awaiting real milestones

A short, draft
company history.

EVERY ENTRY BELOW IS A STUB. REPLACE WITH VERIFIED FACTS, DATES AND PHOTOGRAPHY FROM THE ARCHIVE — SCROLL → FOR THE REST

2003

Founded in Berlin

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Replace with verified founding story — founders, premise, first office.

2007

First Phase III

Sed do eiusmod tempor incididunt ut labore et dolore. Replace with the real first multi-centre study — sponsor, therapeutic area, scale.

2011

Joined IGES Group

Ut enim ad minim veniam, quis nostrud exercitation ullamco. Replace with the real year and circumstances of joining the IGES network.

2014

Athagoras EDC live

Duis aute irure dolor in reprehenderit in voluptate velit. Replace with the actual launch year and capability summary for the in-house EDC.

2018

100 studies delivered

Excepteur sint occaecat cupidatat non proident, sunt in culpa. Replace with a real quantitative milestone worth marking.

2021

DiGA work begins

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Replace with the year CSG started running Erprobungsstudien and DiGA evidence work.

2024

Recent flagship study

Sed ut perspiciatis unde omnis iste natus error sit. Replace with a recent flagship trial or sector expansion worth highlighting.

2026

New website. (Hi.)

The only entry on this timeline that is currently real. You're looking at it.

The wider leadership bench.

Roughly 80 specialists across biostatistics, regulatory, monitoring, medical writing, data management and operations — most with a doctorate, all with at least one regulatory submission in their hands. Here's a sample; the full directory is available on request.

Max Mustermann
Head of Biostatistics
Erika Mustermann
Head of Regulatory
Max Mustermann
Head of Operations
Erika Mustermann
Senior Medical Writer
Max Mustermann
Head of Pharmacovigilance
Erika Mustermann
Head of Data Management
Max Mustermann
Principal Statistician
PART OF IGES GROUP

One of Europe's largest
independent health-research networks.

The IGES Group connects clinical operations, health economics, biostatistics, registry research and policy under a single roof — about 800 specialists across Berlin, Hamburg, Stockholm and Singapore.

IGES InstitutHEALTH ECONOMICS
CSGCLINICAL TRIALS
AthagorasEDC / DATA
IGES NordicREGISTRY

Trusted by the names
you'd expect — and
some you wouldn't.

CLIENT MARK
PARTNER LOGO
UNIVERSITY
HOSPITAL NETWORK
BIOTECH CO.
MED-DEVICE FIRM
PHARMA
DiGA STARTUP
REGISTRY
PUBLIC HEALTH
FOUNDATION
+ 40 MORE

Want to read
your protocol with us?

Get in touch →